Enter the exosome: WVU researcher studies how cancer and immune cells communicate

October 30, 2019

Cells can't text each other the way we can, but they can still communicate. One way they send each other messages is through exosomes--tiny, spherical "packages" of information they emit.

David Klinke, a researcher with the West Virginia UniversitySchool of Medicine and Cancer Institute, is deciphering the contents of exosomes that cancer cells release. Studying the information exosomes contain and how they influence other cells may suggest new targets for cancer immunotherapy.

"Exosomes are like little balls of information relayed between cells," said Klinke, an associate professor in the Benjamin M. Statler College of Engineering and Mineral Resources.

They house multiple proteins, which are the building blocks of cells. They also contain RNAs that provide instructions for making new proteins and manipulate what genes do.

"If we imagine that an individual protein is like a sentence, then an exosome is like an entire book," he said.

Not just the 'garbage can of the cell'

Klinke and his colleagues wanted to learn how the "books" of information that tumor cells send out might interfere with our body's ability to detect and battle tumors. But first they had to find out what the cancer cells were stashing in their exosomes to begin with.

So, they collected exosomes secreted by melanoma, a type of cancer that strikes pigment-producing cells, and identified the types of proteins and RNA they contained.

The researchers discovered that the melanoma cells seemed to selectively package certain proteins and RNAs in their exosomes while withholding others. This finding contradicted the long-held assumption that exosomes contain a random assortment of the cell's contents.

"Early on it was thought that exosomes were kind of the garbage can of the cell, where everything in it was a representation of what's in the cell," Klinke said. "In the last 10 years or so, there's been a re-recognition of exosomes. Folks have gone back to the literature and realized they'd seen these things before but didn't really know what they did. More recently, researchers have been able to separate them out and figure out ways to isolate them. Now we're at the stage of, 'Well, what do they do? What role do they play in cell communication?'"


Subduing the immune response

Next, the team stimulated T cells--a type of immune cell that detects and destroys invaders--so that, under normal conditions, they would recognize melanoma and kill it. Klinke likens the process to getting a flu shot.

"Each T cell recognizes a unique pattern," he said. "This is why you get the flu vaccine. You want to pre-activate those T cells to recognize certain patterns that we expect to see in this year's flu."

Initially, when the researcher exposed the T cells to melanoma, the T cells responded as expected: they quickly multiplied to swarm the cancer. But once the researchers added melanoma exosomes to the sample, "the T cells stopped proliferating," Klinke said. "The exosomes essentially suppressed their response."

The results were published in FEBS Journal, the international journal of the Federation of European Biochemical Societies, in 2018. This year, Klinke and his colleagues-- Christina Byrne-Hoffman, Cassidy Bland, Audry Fernandez, Stephanie Rellick and Wentao Deng--won FEBS' Richard Perham Award for the publication. FEBS invited them to present their findings at the FEBS Congress in Krakow, Poland, this summer.

The team's results indicate that cancer cells may use their exosomes to avoid eradication by subduing T cell activity.

"Exosomes create an environment for tumor cells to survive," Klinke said. "If an exosome is a book of information, it influences how the immune system reacts to its environment. But, if we look at how the immune system reads the information and how that influences the T cell, maybe we could engineer immune cells to ignore or dispose of exosomes that they encounter."

Research reported in this publication was supported by National Institutes of Health under Award Number CA193473 and the National Science Foundation under Award Number CBET-1644932. The findings and conclusions in this article are those of the authors and do not necessarily represent the official position of the funding agencies.

West Virginia University

Related Cancer Articles from Brightsurf:

New blood cancer treatment works by selectively interfering with cancer cell signalling
University of Alberta scientists have identified the mechanism of action behind a new type of precision cancer drug for blood cancers that is set for human trials, according to research published in Nature Communications.

UCI researchers uncover cancer cell vulnerabilities; may lead to better cancer therapies
A new University of California, Irvine-led study reveals a protein responsible for genetic changes resulting in a variety of cancers, may also be the key to more effective, targeted cancer therapy.

Breast cancer treatment costs highest among young women with metastic cancer
In a fight for their lives, young women, age 18-44, spend double the amount of older women to survive metastatic breast cancer, according to a large statewide study by the University of North Carolina at Chapel Hill.

Cancer mortality continues steady decline, driven by progress against lung cancer
The cancer death rate declined by 29% from 1991 to 2017, including a 2.2% drop from 2016 to 2017, the largest single-year drop in cancer mortality ever reported.

Stress in cervical cancer patients associated with higher risk of cancer-specific mortality
Psychological stress was associated with a higher risk of cancer-specific mortality in women diagnosed with cervical cancer.

Cancer-sniffing dogs 97% accurate in identifying lung cancer, according to study in JAOA
The next step will be to further fractionate the samples based on chemical and physical properties, presenting them back to the dogs until the specific biomarkers for each cancer are identified.

Moffitt Cancer Center researchers identify one way T cell function may fail in cancer
Moffitt Cancer Center researchers have discovered a mechanism by which one type of immune cell, CD8+ T cells, can become dysfunctional, impeding its ability to seek and kill cancer cells.

More cancer survivors, fewer cancer specialists point to challenge in meeting care needs
An aging population, a growing number of cancer survivors, and a projected shortage of cancer care providers will result in a challenge in delivering the care for cancer survivors in the United States if systemic changes are not made.

New cancer vaccine platform a potential tool for efficacious targeted cancer therapy
Researchers at the University of Helsinki have discovered a solution in the form of a cancer vaccine platform for improving the efficacy of oncolytic viruses used in cancer treatment.

American Cancer Society outlines blueprint for cancer control in the 21st century
The American Cancer Society is outlining its vision for cancer control in the decades ahead in a series of articles that forms the basis of a national cancer control plan.

Read More: Cancer News and Cancer Current Events
Brightsurf.com is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to Amazon.com.